Keywords: CE-SDS; capillary electrophoresis-sodium dodecyl sulfate; DLS; dynamic light scattering; DSC; differential scanning calorimetry; DSF; differential scanning fluorimetry; FBDS; formulated bulk drug substance; HMWS; high molecular weight species; kDa; kiloda
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Ach; acetylcholine; AChE; cholinesterase; AD; Alzheimer disease; AMT; adsorptive mediated transcytosis; APP; amyloid precursor protein; ARND; age related neurodegenerative disorders; ALS; amyotrophic lateral sclerosis; BBB; blood brain barrier; CMT; carri
Keywords: excipients; protein formulation; stability; surfactants; CMC; critical micelle concentration; HSA; human serum albumin; FFA; free fatty acids; FID; flame ionization detector; ICH; International Council for Harmonisation of Technical Requirements for Pharm
Keywords: proteins; excipients; surfactants; stability; protein aggregation; protein structure; protein formulation; stabilization; protein binding; physical characterization; CD; circular dichroism; DSC; differential scanning calorimetry; Fab; antigen-binding frag
Keywords: BAC; benzalkonium chloride; MGHS40; macrogolglycerol hydroxystearate; PS80; polysorbate 80; HCE-T; human corneal epithelial cell line; HBSS; Hank⿿s balanced salt solution; DPBS; Dulbecco⿿s phosphate buffered saline; DAPI; 4⿲,6-Diamidino-2-phenylindo
Keywords: CAM; clarithromycin; SDS; sodium lauryl sulfate; LCT; soybean lecithin; SFE; sucrose fatty acid ester; PS80; polysorbate 80; POS40; polyoxyl 40 stearate; PEG400; macrogol 400; PXRD; powder X-ray diffraction; L-HPC; low-substituted hydroxypropylcellulose;
Keywords: AE; adverse event; API; active pharmaceutical ingredient; BDP; beclomethasone dipropionate; CF; cystic fibrosis; CFU; colony forming unit; CH; cholesterol; COPD; chronic obstructive pulmonary disease; DLPC; dilauroyl PC; DPI; dry powder inhaler; DPPC; dip
Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch⢠Microprojection Array
Keywords: poliovirus; vaccine; formulation; stability; delivery; Nanopatchâ¢; microarray patch; WPV; wild poliovirus; tOPV; trivalent oral polio vaccine; bOPV; bivalent oral polio vaccine; VAPP; vaccine-associated paralytic poliomyelitis; cVDPV; circulating vaccin
Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon
Keywords: AAD; antibiotic-associated diarrhea; CDAD; Clostridium difficile associated diarrhea; DP; drug product; DS; drug substance; GMS; glycerol monostearate; HPC; hydroxypropyl cellulose; HPMC; hydroxypropyl methylcellulose; IIG; inactive ingredient guide; PS80
Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations
Keywords: enzyme; HPLC; protein; surfactants; mass spectrometry; stability; rLPLA2; recombinant group XV lysosomal phospholipase A2 isomer X1; PS80; polysorbate 80; PS20; polysorbate 20; CHO; Chinese hamster ovary; LC-MS; liquid chromatography-mass spectrometry;
Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity
Keywords: In vitro blood-brain barrier; Poly(n-butylcyano-acrylate); Transendothelial electrical resistance; Drug delivery; Nanoparticles; Polysorbate 80; BBB; blood-brain barrier; PBCA; Poly(n-butylcyano-acrylate; TEER; Transendothelial electrical resistance; PS80